Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

PURPOSE: The clinical efficacy of tamoxifen is suspected to be influenced by the activity of drug-metabolizing enzymes and transporters involved in the formation, metabolism, and elimination of its active forms. We investigated relationships of polymorphisms in transporter genes and CYP2D6 to clinic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Kiyotani, Kazuma, Mushiroda, Taisei, Imamura, Chiyo K., Hosono, Naoya, Tsunoda, Tatsuhiko, Kubo, Michiaki, Tanigawara, Yusuke, Flockhart, David A., Desta, Zeruesenay, Skaar, Todd C., Aki, Fuminori, Hirata, Koichi, Takatsuka, Yuichi, Okazaki, Minoru, Ohsumi, Shozo, Yamakawa, Takashi, Sasa, Mitsunori, Nakamura, Yusuke, Zembutsu, Hitoshi
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2010
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872305/
https://ncbi.nlm.nih.gov/pubmed/20124171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.7246
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi